Only show
results from:

Sort results by:

Display preferences
406 results sorted by relevancy Results per page:
Archemix Corp. Completes $50 Million Series B Financing; Funding to be Used for Development of Archemix's Aptamer Therapeutic Programs.
PR Newswire; Apr 6, 2004; 700+ Words ...April 6 /PRNewswire/ -- Archemix Corp., a biopharmaceutical company...candidates." About Archemix Archemix Corp. is a privately-held biopharmaceutical...info@teminandco.com, for Archemix Corp. Web site: http://www...
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
PR Newswire; May 31, 2006; 700+ Words CAMBRIDGE, Mass., May 31 /PRNewswire/ -- Archemix Corp., the privately- held biopharmaceutical company...excellent, tunable pharmacokinetic properties. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
Boston Scientific Chief Financial Officer, Lawrence C. Best, Joins Archemix Corp. Board of Directors.
PR Newswire; Apr 26, 2005; 700+ Words ...CAMBRIDGE, Mass., April 26 /PRNewswire/ -- Archemix Corp., the privately- held biopharmaceutical company...excellent, tunable pharmacokinetic properties. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
Frank L. Douglas, Former Aventis Executive, Joins Archemix Corp. Board of Directors.
PR Newswire; Mar 22, 2005; 700+ Words CAMBRIDGE, Mass, March 22 /PRNewswire/ -- Archemix Corp., the privately-held biopharmaceutical company...excellent, tunable pharmacokinetic properties. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
FierceBiotech Names Archemix Corp. as One of the "Fierce 15" Biotech Companies of 2007.
Business Wire; Jun 6, 2007; 700+ Words Archemix is "Fierce," on Leading Edge of Biotech CAMBRIDGE, Mass. -- Archemix Corp. today announced it has been named to...partnerships, and competitive market position. Archemix Corp. was determined to be one of the "fiercest...
Included among recent SEC filings for initial public offerings, Archemix Corp. (Cambridge MA) registered 4.5 million shares of common stock via Banc of America Securities LLC.(IPO Sector)
MondayMorning; Oct 29, 2007; 412 Words ...for initial public offerings, Archemix Corp. (Cambridge MA) registered 4...between $12 and $14 per share. Archemix focuses on developing aptamer therapeutics...diseases, as well as cancer. Archemix does not have any products approved...
Archemix Corp.-Company Report.
M2 Presswire; Feb 8, 2009; 593 Words ...8 February 2009-www.companiesandmarkets.com: Archemix Corp.-Company Report(C)1994-2009 M2 COMMUNICATIONS...www.companiesandmarkets.com adds new report: Archemix Corp.-Company Report Private Company Reports provide up...
Archemix Corp.(IPO Sector)(Brief article)
MondayMorning; Aug 6, 2007; 593 Words ...among recent SEC filings for initial public offerings, Archemix Corp. (Cambridge MA) registered up to $69 million worth...aptamers, a type of synthetic oligonucleotide that Archemix believes will trump other cutting edge biotech tools...
Archemix Corp.(Who's Who)
Chemical Engineering; Sep 1, 2004; ; 389 Words Archemix Corp. (Cambridge, Mass.) appoints Augustine Yee vice-president of business development.
Errol De Souza. (Jobs and People).(CEO of Archemix Corp.)(Brief Article)
Chemical Market Reporter; Apr 21, 2003; 422 Words Errol De Souza has been appointed president and CEO of Archemix Corp. Mr. De Souza, most recently president and CEO of Synaptic Pharmaceutical Corp., has experience in drug discovery and product development within both biotechnology and large pharmaceutical settings.
GSK/Archemix deal.(News)(Archemix Corp. and GlaxoSmithKline PLC)(Brief article)
Chain Drug Review; Jan 19, 2009; 619 Words GlaxoSmithKline PLC has secured options to license several drug candidates for inflammatory diseases in a development pact with Archemix Corp. Archemix focuses on so-called aptamer technology, which binds to proteins to fight diseases.
Nuvelo and Archemix expand aptamer accord.(research agreements between Archemix Corp and Nuvelo Inc)(Brief article)
Pharma Marketletter; Aug 14, 2006; 677 Words Archemix and fellow USA-based drugmaker Nuvelo...replaces the existing 50/50 collaboration, Archemix will be responsible for the discovery...will make an initial upfront payment to Archemix of $4.0 million and, under certain...
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics.
PR Newswire; Jan 17, 2007; 700+ Words ...CAMBRIDGE, Mass., Jan. 17 /PRNewswire/ -- Archemix Corp. announced today that it has signed a multi-year...offering a significant cost advantage. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics.
PR Newswire; Jan 9, 2007; 700+ Words CAMBRIDGE, Mass., Jan. 9 /PRNewswire/ -- Archemix Corp. today announced that it has signed an agreement...may offer a significant cost advantage. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer.
PR Newswire; Oct 3, 2006; 700+ Words CAMBRIDGE, Mass., Oct. 3 /PRNewswire/ -- Archemix Corp. announced today the appointment of James Gilbert...offering a significant cost advantage. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
Archemix Appoints Industry Expert James McArdle, Ph.D., as Vice President, CMC.
PR Newswire; Dec 4, 2006; 700+ Words CAMBRIDGE, Mass., Dec. 4 /PRNewswire/ -- Archemix Corp. announced today the appointment of James McArdle...offering a significant cost advantage. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
Archemix Announces Appointment of Larry Gold to its Scientific Advisory Board.
PR Newswire; Apr 28, 2004; 700+ Words ...CAMBRIDGE, Mass., April 28 /PRNewswire/ -- Archemix Corp., the privately- held biopharmaceutical company...aptamers make them ideal diagnostic reagents. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
Archemix CEO to Present at 23rd Annual JPMorgan Healthcare Conference; Monday, January 10, 2005, 9:30 a.m.
PR Newswire; Jan 6, 2005; 700+ Words CAMBRIDGE, Mass., Jan. 6 /PRNewswire/ -- Archemix Corp., the privately-held biopharmaceutical company...excellent, tunable pharmacokinetic properties. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
Archemix Names Augustine Yee Vice President, Business Development; Will Lead Archemix's Outlicensing and Business Development Efforts.
PR Newswire; Aug 5, 2004; 700+ Words CAMBRIDGE, Mass., Aug. 5 /PRNewswire/ -- Archemix Corp., the privately-held biopharmaceutical company...excellent, tunable pharmacokinetic properties. About Archemix Corp. Archemix Corp. is a privately-held biopharmaceutical company...
Archemix Raises Additional $37 Million in Funding; $51.75 Million Series A Round Completed.
PR Newswire; Aug 13, 2002; 700+ Words CAMBRIDGE, Mass. -- Archemix Corp., a pioneer in the discovery and development of...Ph.D., The Scripps Research Institute. About Archemix Archemix Corp. (http://www.archemix.com/) is a privately...
406 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives